Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women

Clinical and Experimental Pharmacology and Physiology

Volumn 42, Issue 2, 2015, Pages 139-145

  Lu, Zhigang ^a   Pan, Xiaoping ^a   Hu, Yaqin ^a   Hao, Yaping ^a   Luo, Yuqi ^a   Hu, Xiang ^a   Ma, Xiaojing ^a   Bao, Yuqian ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Non alcoholic fatty liver disease; Visceral obesity; Vitamin D

Indexed keywords

CALCIFEDIOL; VITAMIN D;

ABDOMINAL OBESITY; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CHINESE; ECHOGRAPHY; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTMENOPAUSE; PREVALENCE; RISK FACTOR; VITAMIN BLOOD LEVEL; ADIPOSE TISSUE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE;

ADIPOSE TISSUE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, ABDOMINAL; POSTMENOPAUSE; RISK FACTORS; VITAMIN D;

EID: 84920923637     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12334     Document Type: Article

References (33)

1. Toth MJ, Tchernof A, Sites CK, Poehlman ET. Effect of menopausal status on body composition and fat distribution. Int. J. Obes. Relat. Metab. Disord. 2000; 24: 226-31.
2. Sowers M, Zheng H, Tomey K et al. Changes in body composition in women over six years at midlife: Ovarian and chronological aging. J. Clin. Endocrinol. Metab. 2007; 92: 895-901.
3. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am. J. Clin. Nutr. 2004; 79: 379-84.
4. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: Analysis of clinical background. J. Gastroenterol. 2003; 38: 954-61.
5. Gutierrez-Grobe Y, Ponciano-Rodríguez G, Ramos MH, Uribe M, Méndez-Sánchez N. Prevalence of nonalcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann. Hepatol. 2010; 9: 402-9.
6. Mizwicki MT, Menegaz D, Yaghmaei S, Henry HL, Norman AW. A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): Structure-function implications. J. Steroid Biochem. Mol. Biol. 2010; 121: 98-105.
7. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am. J. Physiol. Renal. Physiol. 2005; 289: F8-28.
8. 3 levels in patients with nonal-coholic steatohepatitis or hepatitis C virus. Hepatology 2012; 56: 2180-7.
9. Rodríguez-Rodríguez E, Navia-Lombán B, López-Sobaler AM, Ortega RM. Associations between abdominal fat and body mass index on vitamin D status in a group of Spanish school children. Eur. J. Clin. Nutr. 2010; 64: 461-7.
10. Nam GE, Kim do H, Cho KH et al. Estimate of a predictive cut-off value for serum 25-hydroxyvitamin D reflecting abdominal obesity in Korean adolescents. Nutr. Res. 2012; 32: 395-402.
11. Targher G, Bertolini L, Scala L et al. Associations between serum 25-hydroxyvitamin D concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 2007; 17: 517-24.
12. Dasarathy J, Periyalwar P, Allampati S et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2014; 34: e118-27.
13. 3 levels with visceral adipose tissue in Chinese men with normal glucose tolerance. PLoS ONE 2014; 9: e86773.
14. Hao YP, Ma XJ, Luo YQ et al. Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes. Acta Pharmacol. Sin. 2014; 35: 1150-6.
15. Gallagher JC, Riggs BL, DeLuca HF. Effect of estrogen on calcium absorption andserum vitamin D metabolites in postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 1980; 51: 1359-64.
16. Bikle DD. Role of vitamin D, its metabolites and analogs in the management of osteoporosis. Rheum. Dis. Clin. North Am. 1994; 20: 759-75.
17. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J. Clin. Endocrinol. Metab. 2003; 88: 157-61.
18. Sorkin JD, Vasaitis TS, Streeten E, Ryan AS, Goldberg AP. Evidence for threshold effects of 25-hydroxyvitamin D on glucose tolerance and insulin resistance in Black and White obese postmenopausal women. J. Nutr. 2014; 144: 734-42.
19. Rhee EJ, Kim MK, Park SE et al. High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr. J. 2013; 60: 743-52.
20. Barchetta I, Angelico F, Del Ben M et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011; 9: 85.
21. Seo JA, Eun CR, Cho H et al. Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults. PLoS ONE 2013; 8: e75197.
22. Day CP. From fat to inflammation. Gastroenterology 2006; 130: 207-10.
23. Schmidt DR, Holmstrom SR, Fon Tacer K, Bookout AL, Kliewer SA, Mangelsdorf DJ. Regulation of bile acid synthesis by fat-soluble vitamins A and D. J. Biol. Chem. 2010; 285: 14486-94.
24. 3 via the vitamin D receptor. Mol. Pharmacol. 2006; 69: 2013-23.
25. Abramovitch S, Dahan-Bachar L, Sharvit E et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 2011; 60: 1728-37.
26. 3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation. Liver Int. 2013; 33: 677-86.
27. Sharifi N, Amani R, Hajiani E, Cheraghian B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine 2014; 47: 70-80.
28. 3 inhibition of adipogenesis in 3T3-L1 cells. Am. J. Physiol. Endocrinol. Metab. 2006; 290: E916-24.
29. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium. Mechanisms and implications. J. Am. Coll. Nutr. 2002; 21: S146-51.
30. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol. Metab. Clin. North Am. 2010; 39: 419-46.
31. Bao Y, Ma X, Yang R et al. Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J. Clin. Endocrinol. Metab. 2013; 98: 345-51.
32. Wang Y, Ma X, Zhou M et al. Contribution of visceral fat accumulation to carotid intima-media thickness in a Chinese population. Int. J. Obes. (Lond.) 2012; 36: 1203-8.
33. Jian-Gao F, Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: An updated and revised edition. Zhonghua Gan Zang Bing Za Zhi 2010; 18: 163-6. (in Chinese).